Salarius Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$12,542 over the previous period. Total operating expenses were $12,894.
Profit Margin
| 2015 | 0 | -29.14M | |
|---|---|---|---|
| 2016 | 1.01M | -39.49M | -3906.33% |
| 2017 | 1.27M | -34.43M | -2700.71% |
| 2018 | 838K | -21.92M | -2615.99% |
| 2019 | 3.46M | -5.60M | -161.88% |
| 2020 | 5.23M | -7.09M | -135.61% |
| 2021 | 1.84M | -12.70M | -690.37% |
| 2022 | 0 | -31.37M | |
| 2023 | 0 | -12.54K |
SLRX Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 0 | 0 | 1.84M | 5.23M | 3.46M | 838K | 1.27M | 1.01M | 0 |
Cost of revenue | 10.05K | 6.67K | 19.18K | 6.91K | 4.01K | 431K | 507K | 663K | 49.88K |
Gross profit | -10.05K | -6.67K | 1.82M | 5.22M | 3.46M | 407K | 768K | 348K | -49.88K |
Operating exp. | |||||||||
Research and development | 7.17K | 15.83M | 8.54M | 6.91M | 4.01M | 11.90M | 16.99M | 20.37M | 12.74M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 17.13M | 0 | 0 |
Total operating expenses | 12.89K | 22.97M | 14.65M | 12.84M | 11.73M | 22.48M | 35.49M | 40.23M | 29.21M |
Operating income | -12.89K | -31.84M | -12.81M | -7.78M | -9.57M | -22.07M | -34.72M | -39.88M | -29.21M |
Other income (expenses), net | 352 | 233.18K | 44.69K | 434.09K | 2.63M | 152.00K | 291.96K | 393.10K | 72K |
Income before tax | -12.54K | -31.60M | -12.76M | -7.35M | -6.93M | -21.92M | -34.43M | -39.49M | -29.14M |
Income tax expense | 0 | -233.18K | -63.87K | -255.50K | -1.32M | 152.00K | -324.58K | -277.12K | -49.85K |
Net income | -12.54K | -31.37M | -12.70M | -7.09M | -5.60M | -21.92M | -34.43M | -39.49M | -29.14M |
Earnings per share | |||||||||
Basic EPS | -0.00 | -14.77 | -7.68 | -11.39 | -42.9 | -760.47 | -1.24K | -1.52K | -1.29K |
Diluted EPS | -0.00 | -14.77 | -7.68 | -11.39 | -42.9 | -760.47 | -1.24K | -1.52K | -1.29K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |